相关实验视频
Updated: Jul 20, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
在瘤进展,转移和对治疗的反应期间,癌细胞的可塑性
Andrea Pérez-González1, Kevin Bévant1, Cédric Blanpain2,3
1Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Nature cancer
|August 3, 2023
概括
细胞可塑性使细胞能够改变命运,有助于组织修复,但也推动癌症的进展和治疗耐药性. 了解这些机制可以揭示新的抗癌策略.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 再生医学是一种再生医学.
背景情况:
- 细胞可塑性是一种基本的生物过程,使细胞能够改变其身份和功能.
- 这种适应性对于组织平衡和受伤后的再生至关重要.
- 然而,异常细胞可塑性也是癌症发展,进展,转移和治疗耐药性的基础.
研究的目的:
- 在癌症的背景下,审查驱动细胞可塑性的内在和外在机制.
- 阐明细胞可塑性如何促进瘤发作,生长,转移和耐药性.
- 探索利用细胞可塑性的潜力,用于新的抗癌治疗策略.
主要方法:
- 关于影响细胞可塑性的内在和外在因素的综合文献综述.
- 分析与瘤进展和转移相关的分子途径和细胞状态.
- 探索针对细胞可塑性机制的治疗方法.
主要成果:
- 细胞可塑性是由内部细胞程序和外部微环境线索驱动的.
- 细胞状态之间的动态过渡促进瘤细胞的适应,入侵和对治疗的抵抗.
- 控制细胞可塑性的特定分子途径被确定为瘤发生的关键驱动因素.
结论:
- 细胞可塑性是癌症多面性行为的关键决定因素,包括其适应和抵抗治疗的能力.
- 针对细胞可塑性的机制为开发创新的癌症治疗提供了一个有希望的途径.
- 对控制细胞命运过渡的进一步研究可能会彻底改变瘤学.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K

